Literature DB >> 15095805

Spectral analysis of heart rate variability: an emerging tool for assessing stability during transition to extrauterine life.

M Terese Verklan1, Nikhil S Padhye.   

Abstract

Transition from fetal to neonatal life is likely the most physiologically demanding time of life. Complex changes in major organ system functioning and reorganization of metabolic processes must occur rapidly to achieve postnatal homeostasis. Identifying the neonate with subtle signs of unsuccessful transition is a challenge to the perinatal health care provider. Alterations in fetal or neonatal heart rate and heart rate variability may serve as an indicator of the neural control influencing cardiac function and a sensitive indicator of compromised health. Evaluation of the neural control of the heart can be done noninvasively and provides a discriminating measure of the level of stress vulnerability the fetus or newborn may be experiencing. This article reviews the origins of physiological variability of the fetal and neonatal heart rate in the transition to extrauterine life. The technique of spectral analysis as a new tool for surveillance of the at-risk fetus and neonate is then introduced, and implications for clinical practice and future research avenues are discussed.

Mesh:

Year:  2004        PMID: 15095805     DOI: 10.1177/0884217504263301

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  10 in total

1.  Changes in the PQRST intervals and heart rate variability associated with rewarming in two newborns undergoing hypothermia therapy.

Authors:  Robert E Lasky; Nehal A Parikh; Amber L Williams; Nikhil S Padhye; Seetha Shankaran
Journal:  Neonatology       Date:  2009-03-02       Impact factor: 4.035

Review 2.  Autonomic nervous system in newborns: a review based on heart rate variability.

Authors:  Sandra Cardoso; Marta João Silva; Hercília Guimarães
Journal:  Childs Nerv Syst       Date:  2017-05-13       Impact factor: 1.475

3.  Increased Frequency of Skin-to-Skin Contact Is Associated with Enhanced Vagal Tone and Improved Health Outcomes in Preterm Neonates.

Authors:  Megan M Marvin; Fumiyuki C Gardner; Kristin M Sarsfield; R Alberto Travagli; Kim K Doheny
Journal:  Am J Perinatol       Date:  2018-09-07       Impact factor: 1.862

Review 4.  Necrotizing enterocolitis: It's not all in the gut.

Authors:  Alissa L Meister; Kim K Doheny; R Alberto Travagli
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

5.  Cardiac Autonomic Function in the First Hours of Postnatal Life: An Observational Cross-Sectional Study in Term Neonates.

Authors:  Leva A Shayani; Carlos J da Cruz; Luiz Guilherme G Porto; Guilherme E Molina
Journal:  Pediatr Cardiol       Date:  2019-09-16       Impact factor: 1.655

6.  A longitudinal description of heart rate variability in 28--34-week-old preterm infants.

Authors:  Charlene Krueger; JoHannes H van Oostrom; Jonathan Shuster
Journal:  Biol Res Nurs       Date:  2009-11-23       Impact factor: 2.522

7.  Diminished vagal tone is a predictive biomarker of necrotizing enterocolitis-risk in preterm infants.

Authors:  K K Doheny; C Palmer; K N Browning; P Jairath; D Liao; F He; R A Travagli
Journal:  Neurogastroenterol Motil       Date:  2014-04-11       Impact factor: 3.598

8.  Ghrelin ameliorates the phenotype of newborn rats induced with mild necrotizing enterocolitis.

Authors:  Alissa L Meister; Cameron R Burkholder; Kim K Doheny; R Alberto Travagli
Journal:  Neurogastroenterol Motil       Date:  2019-08-06       Impact factor: 3.598

9.  Preterm Stress Behaviors, Autonomic Indices, and Maternal Perceptions of Infant Colic.

Authors:  Fumiyuki C Gardner; Cherie S Adkins; Sarah E Hart; R Alberto Travagli; Kim Kopenhaver Doheny
Journal:  Adv Neonatal Care       Date:  2018-02       Impact factor: 1.968

10.  The protective effect of isosteviol sodium on cardiac function and myocardial remodelling in transverse aortic constriction rat.

Authors:  Qingjin Ke; Fei Liu; Yuxin Tang; Jiedi Chen; Hui Hu; Xiaoou Sun; Wen Tan
Journal:  J Cell Mol Med       Date:  2020-12-17       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.